Pneumoconiosis

Pneumoconiosis is a group of chronic occupational lung diseases caused by the inhalation and deposition of mineral or organic dusts in the lungs, leading to inflammation and fibrosis of the lung tissue. The term encompasses several specific conditions depending on the type of dust inhaled, including silicosis (silica dust), asbestosis (asbestos fibers), coal workers' pneumoconiosis (coal dust), and others such as berylliosis, siderosis, and byssinosis. These diseases primarily affect the respiratory system, causing progressive scarring (fibrosis) of the lung parenchyma, which impairs gas exchange and leads to restrictive or mixed lung disease. Key symptoms include chronic cough, progressive shortness of breath (dyspnea), chest tightness, and reduced exercise tolerance. As the disease advances, patients may develop respiratory failure, pulmonary hypertension, and cor pulmonale (right-sided heart failure secondary to lung disease). Chest imaging typically reveals characteristic nodular opacities, interstitial fibrosis, or pleural abnormalities depending on the specific type of pneumoconiosis. Some forms, particularly asbestosis, carry an increased risk of lung cancer and mesothelioma. Pneumoconiosis is not a genetic disease but rather an environmentally acquired condition resulting from prolonged occupational dust exposure, typically over years to decades. There is no cure, and treatment is primarily supportive, focusing on smoking cessation, avoidance of further dust exposure, pulmonary rehabilitation, supplemental oxygen therapy for hypoxemia, and management of complications. Bronchodilators and corticosteroids may be used in some cases. In severe end-stage disease, lung transplantation may be considered. Prevention through workplace safety measures, proper ventilation, and use of personal protective equipment remains the most effective strategy.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Pneumoconiosis